1. Home
  2. NEUE vs BYSI Comparison

NEUE vs BYSI Comparison

Compare NEUE & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • BYSI
  • Stock Information
  • Founded
  • NEUE 2015
  • BYSI 2010
  • Country
  • NEUE United States
  • BYSI United States
  • Employees
  • NEUE N/A
  • BYSI N/A
  • Industry
  • NEUE
  • BYSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEUE
  • BYSI Health Care
  • Exchange
  • NEUE NYSE
  • BYSI Nasdaq
  • Market Cap
  • NEUE 60.7M
  • BYSI 72.1M
  • IPO Year
  • NEUE 2021
  • BYSI 2017
  • Fundamental
  • Price
  • NEUE $6.40
  • BYSI $1.31
  • Analyst Decision
  • NEUE Hold
  • BYSI
  • Analyst Count
  • NEUE 1
  • BYSI 0
  • Target Price
  • NEUE $7.00
  • BYSI N/A
  • AVG Volume (30 Days)
  • NEUE 19.3K
  • BYSI 24.5K
  • Earning Date
  • NEUE 05-07-2025
  • BYSI 01-01-0001
  • Dividend Yield
  • NEUE N/A
  • BYSI N/A
  • EPS Growth
  • NEUE N/A
  • BYSI N/A
  • EPS
  • NEUE N/A
  • BYSI N/A
  • Revenue
  • NEUE $936,657,000.00
  • BYSI N/A
  • Revenue This Year
  • NEUE $33.99
  • BYSI N/A
  • Revenue Next Year
  • NEUE $5.90
  • BYSI N/A
  • P/E Ratio
  • NEUE N/A
  • BYSI N/A
  • Revenue Growth
  • NEUE N/A
  • BYSI N/A
  • 52 Week Low
  • NEUE $3.79
  • BYSI $0.98
  • 52 Week High
  • NEUE $7.66
  • BYSI $3.63
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 48.94
  • BYSI 44.17
  • Support Level
  • NEUE $6.03
  • BYSI $1.03
  • Resistance Level
  • NEUE $6.84
  • BYSI $1.27
  • Average True Range (ATR)
  • NEUE 0.34
  • BYSI 0.15
  • MACD
  • NEUE 0.03
  • BYSI 0.00
  • Stochastic Oscillator
  • NEUE 48.86
  • BYSI 48.53

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.

Share on Social Networks: